CPhI Festival of Pharma
The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.
Eversana looks to enhance its service in Asia and meet ‘increased’ demand with new offices in Singapore, Mumbai, Shanghai, and Tokyo.
GSK opens two continuous manufacturing facilities and expands an existing production building to shorten timelines in the production of daprodustat.
Biopharmaceutical companies are increasingly relying on CROs in Japan, says an executive with PRA, which recently established a new subsidiary in the country.
Parexel forms a strategic partnership with Clariness to deploy the ClinLife platform in the Greater China area as the CRO looks to recruit and engage patients in their native language and via social media channels.
Novo Nordisk Pharmatech selected DKSH to distribute its pharmaceutical grade compounds to the company’s growing customer base in the Asia-Pacific region.
Novotech will add Oracle’s trial management service, to support its footprint within the Asia-Pacific region.
Catalent’s existing clinical packaging facility in Shanghai is nearing the end of its expansion, ready to meet the needs of the growing Asia-Pacific region.
Japan’s proximity to China, pharmaceutical infrastructure, and workforce capabilities helped inform Biorasi’s decision to launch regional headquarters in Tokyo, says executive.
BioPharmaSpec has set up business development teams for the Indian and Asia-Pacific markets and predicted increased demand for biosimilar characterisation services.
The generic pharmaceuticals company, Mylan, has announced its offer to buy the Swedish specialty pharma company, Meda, in a deal valued at $9.9 bn.
Clinipace Worldwide announced today that it will acquire Choice Pharma, a pan-Asian CRO.
DKSH has acquired Macau-based distributor Glory and says demand for Asian market access is being driven from both Western and local pharma firms.
AMRI's founder has said he will retire and Catalent is looking towards the Asian Pacific market - welcome to Outsourcing-Pharma's People on the Move.
GE Healthcare wont say if its new turnkey biologics plant development service will offer Governments in emerging nations discounted rates.
Rise of Asian biopharm creates investment targets for Quintiles
Quintiles expects to make more investments in Asia-Pacific partnerships as the local biopharm sector grows.
China-focused USP committee to develop excipient standards
USP is creating a China-focused East Asia expert committee to develop quality standards for excipients.
Avacta allies with Pall to serve SE Asian biopharm
Avacta has allied with Pall to offer biopharm manufacturers in Singapore and South Korea tools to assess formulation viability.
CRO Clintec International has opened offices in China, Singapore and Thailand in a move designed to consolidate its presence in the Asia Pacific region.
Study claims Asia is 'a new frontier for clinical development'
A study by research fir, Cutting Edge Information (CEI) claims Asia offers clinical development teams 'unique benefits' for running trials.
PRA expands in Asia-Pacific
US company PRA International has entered into a strategic collaboration with two contract research organizations (CROs) in Southeast Asia in order to tap the fast-growing clinical research market in the region.
China No1 for outsourcing, says PwC
China is the ideal destination for outsourcing, according to a report by PricewaterhouseCoopers (PwC) that has calculated rankings based on a range of parameters.
Daewoong to sell Eurand’s cyclobenzaprine ER
Drug delivery specialist Eurand is to begin supplying its extended release formulation of cyclobenzaprine HCl to South Korea’s Daewoong Pharmaceuticals.
CROs must play greater development role
In the future, drug firms will expect Asian contract research
organizations (CRO) to offer improved discovery, development and
management capabilities, according to Commonwealth Biotechnologies
(CBI) CEO Paul D'Sylva.
BioReliance establishes in Asia Pacific
BioReliance has established itself in the Asia Pacific with the
opening of its first office in the region, in Tokyo, Japan.
Asia glitters gold for pharma
Asia has been dubbed the "land of golden opportunities" by
PricewaterhouseCoopers (PWC), who says it is poised to become the
largest pharmaceutical consumer and producer in the world.
PPD, Novotech and Generex – Clinical contract news
Outsourcing-Pharma.com compiles the news that featured in the
clinical contract community of late, involving PPD, Novotech and
Preclinical presence in Asia continues to gain momentum
The activity of local and international firms establishing
preclinical testing services to good laboratory practice (GLP)
standards in Asia continues to gain momentum.
Preclinical outsourcing to Asia 'off the horizon'
A recent survey reveals that Western pharma companies are still
shying away from outsourcing preclinical work to Asia. Meanwhile,
Covance and Charles River clearly dominate this niche industry
Klockner invests in new Indian packaging plant
German packaging company Klockner Pentaplast (KP) is investing more
than $20m (€15m) in a new pharmaceutical films manufacturing
facility in Aurangabad, India, in a bid to up its presence there.
Companies combine to create high-speed robot
Two companies have teamed-up to create what they claim is one of
the world's fastest robotic packagers.
Indian happi-Ness from Quintiles contract
Ness Technologies is smiling after Quintiles awarded a
multi-million dollar outsourcing contract to the Indian IT services
Clinphone heads down under
As the Asia-Pacific continues to be a hotspot for clinical trials
activity, e-clinical provider ClinPhone has opened its first office
in the region in the hope of gaining a head start.
Quintiles celebrates two industry awards
Top international clinical research organisation (CRO) Quintiles is
celebrating after winning two industry awards for its work in the
Asia Pacific region.
Asia alarming EU medical device makers
Asia is emerging as a hot spot for low-cost medical device
manufacturing as European drug companies pursue outsourcing options
or relocate production to cut costs. This increasing Asian
competition is alarming for European medical...